Presentation TCT 2013 Defining the Optimal Role of AUC in Your Cath Lab Presenter: John Spertus October 30, 2013
Presentation TCT 2013 Treatment of Juxtarenal and Pararenal AAA: Endovascular Options in 2013 Presenter: Jason Lee October 30, 2013
Presentation TCT 2013 Case Presentation Conclusion: Procedural and Patient Outcomes Presenter: Divaka Perera October 30, 2013
Presentation TCT 2013 Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies Presenter: Jodi Akin October 30, 2013
Presentation TCT 2013 Pre-load wtih Platelet ADP Receptor Inhibition in STEMI: Prasugrel, Ticagrelor, Clopidogrel, Or Does it Matter? Presenter: Michel Le May October 30, 2013
Presentation TCT 2013 Navigating the Stent Era (from Bare Metal to Drug-Eluting): The Transformation of PCI Presenter: Patrick Serruys October 30, 2013
Presentation TCT 2013 Role of EVAR in the Treatment of Ruptured AAA Presenter: Christopher Zarins October 30, 2013
Presentation TCT 2013 CHILL-MI: A Prospective, Randomized Trial of Therapeutic Hypothermia in Patients with Acute Myocardial Infarction Undergoing Primary PCI Presenter: David Erlinge October 30, 2013
Presentation TCT 2013 For Mitral Valvuloplasty in Patients with Very Large Left Atrium Presenter: Ted Feldman October 30, 2013
Presentation TCT 2013 Managing the Parade of New Renal Denervation Technology: Are the Clinical Results Generalizable or Device Specific? Presenter: Robert Whitbourn October 30, 2013